Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allogene Therapeutics Inc.

2.05
-0.1300-5.96%
Post-market: 2.050.00000.00%16:05 EDT
Volume:3.92M
Turnover:8.18M
Market Cap:429.83M
PE:-1.33
High:2.20
Open:2.11
Low:1.99
Close:2.18
Loading ...

Allogene Therapeutics to Present New Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Adult Patients with CD70 Positive Advanced Renal Cell Carcinoma (RCC) at the International Kidney Cancer Symposium (IKCS) and Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire
·
05 Nov 2024

Will Allogene Therapeutics (ALLO) Report Negative Earnings Next Week? What You Should Know

Zacks
·
31 Oct 2024

BRIEF-Allogene Therapeutics To Report Third Quarter 2024 Financial Results And Provide Business Update

Reuters
·
30 Oct 2024

Allogene Therapeutics Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Dow Jones
·
30 Oct 2024

Allogene Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update

THOMSON REUTERS
·
30 Oct 2024

Allogene's ALLO-316 Obtains FDA's RMAT Designation for Advanced Renal Cell Carcinoma

MT Newswires Live
·
29 Oct 2024

We Think Allogene Therapeutics (NASDAQ:ALLO) Needs To Drive Business Growth Carefully

Simply Wall St.
·
29 Oct 2024

Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation for Allo-316, an Allocar T™ Investigational Product for Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (Rcc)

THOMSON REUTERS
·
29 Oct 2024

Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ALLO-316, an AlloCAR T™ Investigational Product for Adult Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)

GlobeNewswire
·
29 Oct 2024

BRIEF-Artiva Biotherapeutics Appoints Alison Moore To Its Board Of Directors

Reuters
·
23 Oct 2024

Artiva Biotherapeutics Appoints Alison Moore, Ph.d., to Its Board of Directors

THOMSON REUTERS
·
23 Oct 2024

Analysts Offer Insights on Healthcare Companies: Indivior (GB:INDV), Vor Biopharma (VOR) and Allogene Therapeutics (ALLO)

TIPRANKS
·
15 Oct 2024

Allogene Therapeutics, Inc. (ALLO): Among the Rising Penny Stocks to Invest In Now

Insider Monkey
·
03 Oct 2024

ALLO Communications Lays Foundation for Groundbreaking Business and Residential Experiences Over 50G PON Delivered With the Calix Broadband Platform

Business Wire
·
25 Sep 2024

IGM Biosciences (IGMS) Surges 11.6%: Is This an Indication of Further Gains?

Zacks
·
18 Sep 2024

Allogene Therapeutics, Inc. (ALLO): Short Seller Sentiment is Bearish on This Cancer Stock

Insider Monkey
·
15 Sep 2024